期刊文献+

Ki-67在GCB及non-GCB弥漫性大B细胞淋巴瘤中的表达及意义 被引量:7

Expression and significance of Ki-67 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas
下载PDF
导出
摘要 目的探讨Ki-67在GCB及non-GCB型弥漫性大B细胞淋巴瘤中的表达及意义。方法收集60例DLBCL及19例淋巴结反应性增生组织,并制作其组织芯片,采用免疫组化观测CD1O、bcl-6、MUM1蛋白的表达对DLBCL进行生发中心样B细胞(germinal center B cell-like,GCB)和非生发中心样B细胞(non-GCB)免疫表型分类,同时检测Ki-67蛋白的表达。结果 (1)60例DLBCL中CD1O、bcl-6、MUM1蛋白的阳性表达率分别为33.3%、45%、63.3%,GCB类型29例(48.3%),non-GCB类型31例(51.7%)。(2)Ki-67蛋白在淋巴结反应性增生(不包括生发中心)阳性率明显低于DLBCL(P<0.05)。(3)Ki-67蛋白的表达在DLBCL中GCB及non-GCB亚型中有显著性差异(P<0.05)。结论 Ki-67的表达可能与DLBCL免疫学分型有关,在non-GCB中,Ki-67高表达。 Objective To investigate the expression and significance of Ki-67 in germinal centre B-cell like(GCB)and non-germinal centre B-cell like(non-GCB) diffuse large B-cell lymphomas(DLBCL).Methods A tissue chip cotaining 60 cases of DLBCL and 19 cases of reactive hyperplasia of lymph nodes was constructed,using CD10,BCL-6,MUM1,the cases of DLBCL were subtyped molecuiary into GCB and non-GCB groups and the expression of Ki-67 protein were studied.Results(1)60 cases in DLBCL BCL-6,CD10,MUM1 protein positive expression rate were 33.3%,45%,63.3% respectively,GCB type 29 patients(48.3%),non-GCB type 31 cases(51.7%).(2) Ki-67 protein in lymph node reactive hyperplasia(not including germinal centers) were significantly lower than DLBCL(P0.05).(3) Ki-67 protein expression in DLBCL in GCB and non-GCB subtypes were significantly different(P0.05).Conclusion Ki-67 expression may be related with the immunosubgroups of DLBCL.in non-GCB,Ki-67 high expression.
出处 《江西医药》 CAS 2011年第2期111-114,共4页 Jiangxi Medical Journal
基金 江西省卫生厅科研基金资助(项目编号:052017)
关键词 KI-67 弥漫性大B细胞淋巴瘤 组织芯片 Ki-67 diffuse large B cell lymphoma tissue chip
  • 相关文献

参考文献11

  • 1张彦宁,周小鸽,张淑红,王鹏,张长淮,黄受方.非霍奇金B细胞淋巴瘤369例病理形态观察 2001年世界卫生组织淋巴组织肿瘤新分类应用体会[J].中华病理学杂志,2005,34(4):193-197. 被引量:36
  • 2Steven HS .WHO Classifcation of Tumors of Tumors of Haematopoietic and Lymphoid Tissues .4 ed.France:International Agency for Research on Cancer(IARC),2009.234.
  • 3王爱华,沈志祥.弥漫性大B细胞淋巴瘤.见:恶性淋巴瘤.沈志祥.朱雄增主编.第1版.北京:人民卫生出版社.2003.503.
  • 4Hans CP ,Weisenburger DD, Greiner TC ,et al. Confirmation ofthet molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarry .Blood ,2004,103:275.
  • 5Jovanovi MP, Jakovi L, Bogdanovi A ,et al. Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bc1-2 and Ki 67-positive tumor cells. Vojnosanit Pregl, 2009,66(9):738.
  • 6Pasqualucc L, Neumeister P, Goossens T, et al .Hypermutation of multiple Proto--oncogenes in B-cell diffuse large cell lymphoma . Nature,2001,412:341.
  • 7Ree HJ, Yang WI, Kim CW, FIuh J, Lee SS, Cho EY, et al. Coexpression of Bcl-6 and CD 10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-ceB lymphoma. Hum Pathol ,2001 ,32:954.
  • 8Ohshima K, Kawasaki C, Muta I-I, Deyev V, Haraoka S, Suzumiya J,et al. CD10 and Bcll0 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology ,2002,39: 156.
  • 9Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human imn~unodeficiency virus-related lymphomas. Blood,2001,97:744.
  • 10Natkunam Y, Wamke RA. Montg onery K,et al .Analysis of MUM1/ IRF4 protein expression using tissue microarrays and inmunohistochemistry .Mod Pathol ,2001,14 (7) :686.

二级参考文献17

  • 1肖畅,苏祖兰,吴秋良,郜红艺,方建晨,夏忠军,管忠震.根据WHO新分类对493例非霍奇金淋巴瘤的临床病理分析[J].中华病理学杂志,2005,34(1):22-27. 被引量:54
  • 2The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin′s Lymphoma. Blood, 1997, 89: 3909-3918.
  • 3Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of Multiple Proto-oncogenes in B-cell diffuse Large cell lymphoma. Nature, 2001, 412:341-346.
  • 4Harris NL, Stein H, Coupland SE, et al. New approaches to lymphoma diagnosis(am soc hematol educ program). Hematology, 2001, 194-220.
  • 5Camacho FI, Mollejo M, Mateo MS, et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol,2001, 25:1268-1276.
  • 6Jaffe ES, Harris NL, Stein H, et al.eds. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press,2001.
  • 7Anderson T, Bender RA, Fisher RI, et al. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term follow up. Cancer Treat Rep, 1977, 61:1057-1066.
  • 8Yegappan S,Schnitzer B,Hsi ED. Follicular lymphoma with marginal zone differentiation:microdissection demonstrates the t (14;18) in both the follicular and marginal zone components. Mod Pathol,2001,14:191-196.
  • 9Schmid U, Cogliatti SB, Diss TC, et al. Monocytoid/marginal zone -cell differentiation in follicle centre cell lymphoma. Histopathology, 1996, 29:201-208.
  • 10Martin AR, Weisenburger DD, Chan WC, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood, 1995, 85: 3671-3678.

共引文献35

同被引文献91

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部